)

Repligen (RGEN) investor relations material
Repligen Bank of America Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and strategy
Positioned as an innovation leader in bioprocessing, focusing on disruptive technologies and a differentiated portfolio for biopharma and CDMO customers.
80% of the portfolio faces little direct competition, creating new market segments and supporting global manufacturing with dual-sourcing strategies.
Achieved rapid growth through both organic innovation and 15 acquisitions over 11 years, now offering a broad product range with only a few workflow gaps.
Strategy centers on bioprocessing, productivity gains, disciplined M&A, and a nimble, collaborative culture that has expanded relationships with major pharma and CDMOs.
Tenfold revenue growth in a decade, with a tripled addressable market now at $14 billion, and strong prospects for continued outperformance.
Market performance and segment trends
Mid-teens topline growth in 2025, with all product franchises performing well and chromatography showing a strong recovery.
Order strength is broad-based, with significant recovery in both biopharma and CDMO segments, while small biotech remains muted due to funding challenges.
CDMO growth is robust among both large and small players, with mid-scale CDMOs showing emerging strength.
Product lines are expected to grow at similar rates, with targeted investment to accelerate select segments.
Customer base and product mix have diversified significantly, reducing concentration risk and increasing resilience.
Innovation, new modalities, and technology
80% of the portfolio is differentiated, with examples like ATF technology and double-stranded RNA purification resin creating new solutions.
New modalities now represent 20% of the portfolio, driven by nimbleness and rapid innovation, with a focus on smaller but high-growth opportunities.
Diversification across modalities and programs helps offset headwinds in specific areas, such as gene therapy.
ATF and TFF technologies are key growth drivers, with deep expertise and strong market positioning.
Hardware innovation, such as real-time protein measurement, is expected to become essential for customers.
Next Repligen earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage